Skip to content

688575.SH

Shenzhen YHLO Biotech Co., Ltd.

SSE · Healthcare · Medical - Specialties · CN

CNY 11.32
−0.88%
Ask drillr
  • Oct 28, 2026, 09:12 UTC

    YHLO reported third-quarter 2026 revenue of 541 million yuan, up 13.07% year over year, attributable net profit of 73.4173 million yuan, up 114.97%, and adjusted net profit of 78.5589 million yuan, up 54.45%; for the first nine months of 2026, revenue was 1.429 billion yuan, up 11.04%, attributable net profit was 144 million yuan, up 137.58%, and adjusted net profit was 152 million yuan, up 50.66%.

  • Aug 17, 2026, 09:34 UTC

    Yalun Biotechnology received medical device registration certificates from Guangdong Provincial Drug Administration for two microfluidic chemiluminescence immunoassay analyzers (iNexaLume-A and iNexaLume-B), valid until August 12, 2031.